CLINICAL_TRIALS
trial_result
· 2012-02-22
Clinical Trial Update: A Study of Olanzapine in Patients With Schizophrenia [Phase 3]
Summary
Phase 3 clinical trial update assessing olanzapine in patients with schizophrenia; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2012-02-22